Estimates and valuation unchanged
27/08/26 -"The target price is unchanged as we make no material changes to our estimates or valuation. While organic growth is likely to remain subdued in H2 2026, reflecting portfolio management in Europe, ..."
Pages
48
Language
English
Published on
27/08/26
You may also be interested by these reports :
27/08/26
The target price is unchanged as we make no material changes to our estimates or valuation. While organic growth is likely to remain subdued in H2 ...
12/08/26
Bilfinger’s Q2 revenue grew by 7% to €1.45bn and EBITA by 4% to €77m, both slightly ahead of expectations, but the underlying picture weakened. The ...
06/08/26
Q2 2026 confirmed solid revenue growth, driven by Adecco GBU’s strong performance across the Americas, Asia Pacific and most EMEA regions. While ...
05/08/26
When we last teased on Rentokil (RTO) (REDUCE; UK) ~16 months ago, our optimism stemmed from on-track Terminix integration. The stock price also ...